MWAN
AVNS

Mariner Wealth Advisors (NYC)’s Avanos Medical AVNS Stock Holding History

Mariner Wealth Advisors (NYC)’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$6K Buy
+112
New +$5.19K ﹤0.01% 460

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
RP
RR Partners New York $929M AUM 110.28% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Mariner Wealth Advisors (NYC)'s AVNS Position: Q1 2015 in Review

Mariner Wealth Advisors (NYC) opened a new position in Avanos Medical (AVNS) in Q1 2015: 112 shares worth $6K. The stake represents ﹤0.01% of the portfolio and ranks #460 among its holdings.

448 funds tracked by Wall St. Rank hold AVNS as of Q1 2015.

  • Mariner Wealth Advisors (NYC) held 112 shares of Avanos Medical worth $6K as of Q1 2015.
  • Avanos Medical was a new Mariner Wealth Advisors (NYC) position in Q1 2015.
  • Avanos Medical made up ﹤0.01% of Mariner Wealth Advisors (NYC)'s portfolio in Q1 2015, its #460 holding.
  • 448 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2015.

Based on Mariner Wealth Advisors (NYC)'s 13F filing for Q1 2015, filed 14 May 2015.